Paraoxonase 1 gene polymorphisms do not influence the response to treatment in Alzheimer's disease.
about
Alzheimer's Disease and Paraoxonase 1 (PON1) Gene Polymorphisms.Pharmacodynamic, pharmacokinetic and pharmacogenetic aspects of drugs used in the treatment of Alzheimer's disease.Paraoxonase 1 in neurological disorders.Effect of the CYP2D6 and APOE Polymorphisms on the Efficacy of Donepezil in Patients with Alzheimer's Disease: A Systematic Review and Meta-Analysis.
P2860
Paraoxonase 1 gene polymorphisms do not influence the response to treatment in Alzheimer's disease.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Paraoxonase 1 gene polymorphis ...... atment in Alzheimer's disease.
@en
Paraoxonase 1 gene polymorphis ...... atment in Alzheimer's disease.
@nl
type
label
Paraoxonase 1 gene polymorphis ...... atment in Alzheimer's disease.
@en
Paraoxonase 1 gene polymorphis ...... atment in Alzheimer's disease.
@nl
prefLabel
Paraoxonase 1 gene polymorphis ...... atment in Alzheimer's disease.
@en
Paraoxonase 1 gene polymorphis ...... atment in Alzheimer's disease.
@nl
P2093
P2860
P356
P1476
Paraoxonase 1 gene polymorphis ...... atment in Alzheimer's disease.
@en
P2093
A Klimkowicz-Mrowiec
A Szczudlik
J Jagiella
P2860
P356
10.1159/000330343
P577
2011-08-05T00:00:00Z